Substance Use Disorders and Homelessness: Care Barriers and Recovery Support

Author: Angela Bogdanova · Published: October 19, 2026 · Editorial Policy

Research cluster: Substance Use Disorders and Addiction Recovery · Written by Artificial Sapiens

Why Housing and Substance Use Disorders Must Be Studied Together

Substance use disorders (SUDs) and homelessness intersect through health, housing markets, income insecurity, trauma, stigma, and service design. A person can lose housing while living with a substance use disorder, develop hazardous patterns of use while experiencing homelessness, or move between episodes of housing stability and instability. The relationship is often bidirectional, shaped by common upstream conditions and by the consequences of both experiences. Clinical care therefore needs to address substance-related symptoms and the practical conditions under which treatment can be reached, started, and sustained. Stable housing improves the opportunity to store medication, sleep, maintain contact with clinicians, and pursue personally meaningful recovery goals. Housing by itself does not guarantee remission or reduced substance use. ASAM, 2025.

The central clinical question is how people experiencing homelessness or housing instability can access effective, continuous, respectful substance use disorder treatment and recovery support. An effective response combines immediate safety, accessible evidence-based treatment, housing navigation, integrated physical and mental health care, and long-term social support. Interventions are evaluated against separate outcomes: treatment initiation, retention, substance-related harms, overdose, housing stability, health, functioning, and patient-defined well-being. Improvement in one outcome must not be silently treated as proof of improvement in every other outcome. O'Leary et al., 2025; Baxter et al., 2019.

Definitions and Clinical Boundaries

Homelessness and Housing Instability

Homelessness includes sleeping outdoors, living in shelters or places not intended for habitation, and other situations of lacking secure accommodation. Broader housing instability includes repeated forced moves, imminent eviction, precarious temporary stays with others, overcrowding, and unsustainable housing costs. Legal and research definitions vary by jurisdiction and study, so prevalence estimates should always be interpreted in relation to the population sampled. Unsheltered, sheltered, recently housed, and temporarily doubled-up groups may face different dangers and service barriers. A recorded address is an inadequate substitute for assessing current safety, privacy, tenure, and the person's realistic ability to remain housed.

Housing status is a social and structural circumstance, not a psychiatric diagnosis. A clinical assessment may document that someone's housing situation affects medication access, nutrition, safety, transportation, and ability to attend appointments, while separately determining whether criteria for a substance-related disorder are met. Language such as “person experiencing homelessness” places the person before a potentially temporary condition and avoids turning housing status into an identity or moral judgment.

Substance Use, Risky Use, Dependence, and Disorder

Substance use means consumption of alcohol, nicotine, medications, or other psychoactive substances. Risky use is a pattern associated with elevated potential harm, without necessarily meeting criteria for a mental disorder. The expression substance misuse is used inconsistently and requires clarification of the specific behavior and risk. A substance use disorder is diagnosed through an established clinical framework that evaluates a maladaptive pattern of use, impaired control, consequences, and associated features. Alcohol, opioid, stimulant, sedative, and other substance disorders involve different intoxication, withdrawal, and treatment profiles. Physical dependence and tolerance are pharmacologic adaptations and can occur during appropriate prescribed therapy; neither alone establishes addiction. Compulsive substance seeking or use despite significant harm is central to many clinical conceptions of addiction. ASAM/AAAP, 2024.

A screening instrument signals when further assessment is warranted. Diagnosis requires a qualified clinician to evaluate the relevant criteria, impairment, history, context, and differential explanations. Acute intoxication is an immediate substance effect; overdose is potentially life-threatening toxicity; withdrawal follows reduction or cessation in a physiologically adapted person; and chronic SUD concerns a longer clinical pattern. Remission refers to defined symptom criteria over time, while recovery can encompass relationships, housing, participation, physical health, safety, and sustained functioning. A return to substance use should prompt renewed assessment and engagement rather than automatic abandonment of care. For the distinct diagnostic framework, see Substance Use Disorder: Symptoms, Diagnosis, and Treatment.

What the Epidemiologic Evidence Shows

High Burden, Unequal Exposure, and Selection Effects

Studies consistently identify a high burden of mental disorders and substance-related disorders among samples of people experiencing homelessness, yet results vary considerably across countries, sampling frames, sheltered and unsheltered settings, diagnostic methods, and time periods. A 2024 systematic review and meta-analysis in JAMA Psychiatry documented substantial between-study heterogeneity in pooled estimates. It would be incorrect to apply a single prevalence estimate to every city, subgroup, or person without housing. It would also be incorrect to presume that anyone experiencing homelessness has a substance use disorder. JAMA Psychiatry systematic review, 2024.

People who appear in emergency departments, shelters, or specialty treatment cohorts are not necessarily representative of all people with housing insecurity. Frequent contact with institutions may make severe conditions more visible in administrative data, while people avoiding services may be missed. Self-report can be influenced by fear of eviction, prosecution, loss of benefits, or child-custody consequences. Research based on service use must be interpreted alongside community-based studies and lived-experience research.

Bidirectional Risk and Common Causes

Several pathways connect housing instability and SUD. Substance-related health or occupational impairment may undermine income and relationships. Conversely, displacement and exposure to violence may intensify stress, disrupt sleep, reduce treatment access, and change the environments in which substances are used. Poverty, discrimination, disability, shortage of affordable housing, exposure to trauma, and limited health coverage may precede both housing loss and substance-related problems. These pathways operate at different times and with different weights for different people. The epidemiologic association does not establish that substance use caused a particular person's homelessness. ASAM, 2025.

Longitudinal research, natural experiments, and randomized housing or service interventions can clarify some causal pathways. Still, changing housing may alter health-care contact, exposure to violence, and employment without immediately changing substance consumption. Individual behavior, housing policy, social protection, service availability, and neighborhood environments belong in a multilevel account of causation.

How Housing Instability Changes the Course of Addiction Care

Exposure, Stress, Trauma, and Survival Priorities

Unstable accommodation can generate continuous demands: finding a safe place to sleep, protecting belongings, accessing bathrooms, obtaining food, managing weather, and avoiding victimization. These demands compete with treatment scheduling and recovery activities. Stress and sleep disruption can affect emotion regulation and increase vulnerability to substance-related cues, but neurobiological explanations should remain grounded in the individual clinical pattern rather than treated as a uniform diagnosis. Histories of trauma, loss, coercion, and interpersonal violence warrant sensitive assessment. The recovery experiences of homeless service users, 2024.

A person may use a substance to cope with cold, fear, pain, sleeplessness, or social distress while also experiencing harmful consequences from that use. Describing the context can improve clinical formulation without assuming the behavior is harmless or unavoidable. Research on self-medication and negative reinforcement addresses potential mechanisms; the homelessness-specific article concerns how the care environment can reduce immediate risks and expand realistic treatment choices.

Overdose and Acute Physical Dangers

Housing instability can increase exposure to unpredictable drug supply, solitary consumption, interruptions in treatment, and difficulty obtaining emergency help. Opioid overdose may involve slow or absent breathing, unresponsiveness, and dangerous loss of oxygen. Emergency services should be called immediately; naloxone should be given when an opioid overdose is suspected and available, with rescue breathing or CPR according to dispatcher guidance and training. Naloxone does not replace urgent assessment, and further doses may be needed under local instructions. Stimulant toxicity may present with chest pain, seizures, severe agitation, hyperthermia, or altered mental status, which warrant emergency care. CDC, Treating Opioid Use Disorder; ASAM/AAAP, 2024.

Severe alcohol withdrawal and sedative or benzodiazepine withdrawal can include seizures, delirium, and potentially fatal complications. People with significant physiologic dependence should be clinically assessed before attempting abrupt cessation. Withdrawal management may be necessary for immediate medical stabilization, but sustained disorder treatment and housing support are additional tasks. Patients with severe confusion, seizures, dangerous breathing changes, collapse, severe chest pain, suicidal intent, or suspected overdose need emergency evaluation. This article does not provide unsupervised withdrawal schedules or medication doses.

Infectious Disease, Injury, and Chronic Conditions

Exposure to contaminated injection equipment, crowded conditions, poorly healing wounds, and interruption of basic medical care can increase vulnerability to HIV, viral hepatitis, bacterial infections, skin and soft-tissue complications, and other illnesses. Prevention can include vaccination, testing, sterile supplies where available, wound care, linkage to HIV prevention and treatment, and hepatitis C care. Chronic pain, respiratory disease, disability, malnutrition, and dental problems also affect care planning. The practical goal is coordinated treatment rather than a sequence in which every non-addiction health problem must wait until abstinence. WHO and UNODC, International Standards.

Why People Cannot Reliably Reach Conventional Treatment

Administrative and Financial Barriers

Identification documents, health insurance, proof of residence, enrollment procedures, telephone access, appointment portals, transportation costs, and rigid office schedules may block treatment before a clinical conversation takes place. Requirements to attend repeated in-person visits are especially burdensome when belongings or shelter beds may be lost during an appointment. Insurance lapses and jurisdictional rules can interrupt medications and continuity. Programs can reduce these barriers by coordinating enrollment, offering walk-in or same-day access, facilitating documentation, providing transportation assistance, and maintaining alternative contact arrangements. SAMHSA, Treatment for Individuals Experiencing Homelessness.

Fragmented Care and Exclusionary Rules

People with SUD may be passed between housing, behavioral health, primary care, emergency medicine, justice, and social services, each with different eligibility rules and documentation. A shelter may demand abstinence while a treatment provider requires stable housing or a regular contact number. Sequential prerequisites can form a service loop that denies access to both. Discharging a patient solely because substance use recurs is particularly likely to disrupt continuity during elevated-risk periods. The American Society of Addiction Medicine advises services to improve engagement and retention among nonabstinent patients through welcoming, trauma-sensitive approaches and alternatives to administrative discharge. ASAM, Engagement and Retention Guidance.

Stigma, Discrimination, and Trust

Anticipated judgment, punitive encounters, discrimination, or previous breaches of trust can make a person reluctant to disclose use or accept a referral. Stigma may be compounded by racism, disability, gender identity, migration status, criminalization, or poverty. Clinicians can explain confidentiality boundaries, ask permission before sensitive questions, document neutrally, and offer choices that preserve dignity. Peer workers and outreach personnel with relevant lived experience may help build trust, provided their roles, safeguarding, supervision, and clinical referral pathways are clear. Qualitative evidence suggests that the quality of interactions and the experience of autonomy influence whether services feel enabling or obstructive. O'Leary et al., 2025 qualitative synthesis.

Safety and Practical Retention Barriers

Lost medications, theft, weather exposure, lack of secure storage, inadequate food, unreliable internet, competing case-management demands, and difficulty sleeping can interrupt even a well-chosen treatment plan. Apparent missed appointments should be interpreted against these constraints. Flexible follow-up, outreach, longer medication continuity when clinically appropriate, reminders chosen by the patient, and pharmacy coordination can reduce preventable disruption. Clinicians should ask what actually happened rather than label every interrupted contact as poor motivation.

Clinical Assessment That Recognizes Housing Circumstances

Engagement Begins With Safety and Priorities

An initial clinical encounter should identify immediate threats—overdose, intoxication, dangerous withdrawal, suicidal crisis, injuries, acute infection, and the absence of a safe place to sleep. The professional should then ask about the person's own priorities, recent substance use, prior overdose, prescribed medications, medical history, mental health symptoms, trauma exposure where relevant, and realistic means of returning for care. A person may prioritize food, warmth, documents, or secure storage before discussing a long-term recovery plan. Meeting immediate needs can establish the conditions for further engagement. WHO and UNODC, International Standards.

Screening, Diagnosis, and Severity

Validated alcohol and drug screening tools can help identify potential problems, although their performance depends on setting and population. A positive screen should lead to compassionate diagnostic evaluation, not automatic labeling. The clinician determines whether there is a substance use disorder, whether withdrawal or intoxication is present, and whether concurrent depression, psychosis, PTSD, anxiety, cognitive impairment, physical illness, or prescribed-medication effects require evaluation. Housing insecurity may influence symptom reports and observed functioning, so clinical interpretation should attend to context.

Multidimensional Assessment and Care Placement

Level-of-care decisions should integrate withdrawal and intoxication risk, biomedical conditions, emotional and cognitive concerns, likelihood of serious harm, recovery environment, patient preferences, and ability to access services. A conventional outpatient plan may be clinically appropriate yet practically inaccessible without transportation or a safe place to store medicine. Conversely, homelessness alone does not automatically require inpatient admission or residential addiction treatment. Care intensity should reflect clinical need while housing assistance is pursued in parallel. Periodic reassessment matters as circumstances change. See Substance Use Disorder: Symptoms, Diagnosis, and Treatment.

Consent, Privacy, and Information Sharing

Coordination across agencies benefits from clear consent and limited, necessary exchange of information. A person's disclosure of substance use should not circulate indiscriminately among landlords, shelters, employers, or agencies. Clinicians should explain local confidentiality law, relevant exceptions, documentation practices, and the practical implications of sharing information. Access to coordinated care should be built around patient agency and information security.

Housing Models and What Each Can Achieve

Housing First and Permanent Supportive Housing

Housing First prioritizes access to permanent housing without making sobriety or treatment completion a precondition, often coupled with voluntary support services. Permanent supportive housing adds ongoing assistance for people with substantial needs. Randomized evidence supports improvement in housing stability, while effects on substance consumption and many health measures are less certain or heterogeneous. In a systematic review of four randomized studies, Baxter and colleagues found more favorable emergency-department and hospital-use outcomes for Housing First but no clear overall difference in substance use; the studies had high risk of bias. A housing outcome therefore should be reported as such, without assuming automatic addiction remission. Baxter et al., 2019.

Program implementation differs across places: rental availability, support staffing, access to mental health care, choice of housing, and landlord participation affect outcomes. Some participants may need more intensive integrated services after housing placement; others may choose lighter follow-up. Housing is a platform from which clinical and social goals can be pursued, with its own legitimate endpoint of security and stability.

Recovery Housing and Abstinence-Oriented Settings

Recovery housing often provides a substance-free shared living environment and mutual accountability for residents who want that model. Programs vary in governance, quality, peer support, clinical integration, affordability, and length of stay. A 2025 systematic review found five eligible comparative studies—three randomized trials and two quasi-experimental designs—suggesting improvements in abstinence and some employment and income outcomes. The small evidence base, varied programs, and selection differences constrain generalization. Recovery housing should be presented as one option aligned with patient goals, not a universal housing prerequisite for receiving treatment. Recovery housing systematic review, 2025.

Transitional Shelter, Medical Respite, and Rapid Rehousing

Emergency shelter can protect people from immediate environmental threats but may involve crowding, limited privacy, storage restrictions, and time-limited access. Medical respite offers short-term recuperative care to people too ill to recover safely without housing but who do not necessarily need hospitalization. Rapid rehousing focuses on obtaining accommodation, sometimes with short-term financial assistance. These interventions operate on different time horizons and have different eligibility criteria and evidence bases. A clinician should clarify whether a proposed placement is actually available, safe, accessible, and compatible with ongoing medications and care.

Choosing Without Making Housing Conditional on Treatment Success

Some people seek abstinence-oriented recovery housing; others benefit from low-barrier permanent housing or a different model. Matching should account for safety, disability access, family situation, personal preference, substance-related risk, program rules, and the ability to maintain medical treatment. A system that makes every shelter or apartment conditional on sustained abstinence can create avoidable exclusion precisely when safety is needed most. At the same time, programs offering a substance-free setting may meet an important preference for residents who choose it. The outcome to protect is a real, safe housing pathway combined with access to appropriate care.

Evidence-Based Addiction Treatment in Homelessness Services

Opioid Use Disorder: Medication Access and Retention

Buprenorphine and methadone are established treatments for opioid use disorder, reducing illicit opioid use and important health risks when appropriately delivered; extended-release naltrexone can be useful for selected patients after the necessary clinical prerequisites are met. Homelessness should trigger efforts to make treatment accessible rather than exclusion from medication. In a scoping review of 60 studies, people experiencing homelessness faced additional barriers to opioid treatment and were more often routed toward detoxification or inpatient services than maintenance pharmacotherapy. Outcomes among people engaged in medication care could be similar to those of housed patients, though the heterogeneous and predominantly observational evidence does not justify a universal equivalence claim. Opioid treatment scoping review, 2021; CDC.

Low-barrier medication models can include walk-in engagement, flexible follow-up, outreach, coordination with pharmacies, support with insurance, and re-entry after missed visits. A Boston cohort of 1,467 patients receiving tailored office-based addiction treatment documented substantial mortality risk; recent program attendance was associated with lower mortality. Because this was observational, the association cannot establish that attendance alone caused the difference. Still, it underscores why consistent access matters even when complete abstinence has not been achieved. Office-Based Addiction Treatment Retention and Mortality, 2021.

Alcohol Use Disorder and Safer Continuity of Care

Alcohol use disorder treatment may involve psychosocial care, medications such as naltrexone or acamprosate when clinically appropriate, management of associated medical conditions, and long-term follow-up. Housing instability may complicate nutrition, liver disease assessment, medication access, and safe withdrawal monitoring. Heavy physiologic dependence requires assessment for potentially severe withdrawal; abrupt unsupported cessation may be dangerous. Some specialized managed-alcohol programs have been studied as harm-reduction services for people with severe alcohol dependence and repeated homelessness, but evidence remains more limited and context-specific than for standard evidence-based alcohol use disorder treatment. Treatment goals and housing support should be coordinated rather than imposed in a fixed sequence. Review of substance-use interventions in homeless populations, 2020.

Stimulant Use Disorder and Behavioral Treatment

For stimulant use disorder, the ASAM/AAAP guideline identifies contingency management as a primary evidence-supported behavioral intervention. Other psychosocial treatments and co-occurring symptom management can contribute, and selected medications are studied or used in specific circumstances with more limited evidence. Care for people without stable housing should consider transportation, regular access to incentives or visits, psychiatric symptoms, nutrition, sleep, and cardiovascular risk. Emergency stimulant intoxication requires prompt medical assessment when there are severe symptoms. ASAM/AAAP, 2024.

Multiple Substances and Co-occurring Disorders

Alcohol, opioids, sedatives, stimulants, and prescribed medications can interact, including combinations that amplify sedation and respiratory depression. Co-occurring mental health conditions are common enough to make integrated assessment essential, while specific diagnosis requires individual evaluation. Trauma histories, suicidality, psychotic symptoms, chronic pain, and pregnancy can alter treatment plans. Serious psychiatric symptoms and SUD should be addressed in a coordinated process rather than requiring one condition to disappear before treating the other. For the independently owned topic of suicide-risk assessment in SUD, see Substance Use Disorders and Suicide Risk: Evidence, Assessment, and Safety.

Why Withdrawal Management Alone Is Insufficient

Medically supervised withdrawal may be essential for stabilization, but it neither provides permanent housing nor substitutes for continuing addiction care. Completion of detoxification without continuing opioid agonist treatment can leave a person at high risk because tolerance decreases while drug exposure may recur. A safe transition plan must address follow-up, medication continuity, overdose education, naloxone where appropriate, and housing placement. Health professionals should avoid discharging someone into a situation in which essential medical steps are impractical. CDC, Treating Opioid Use Disorder.

Harm Reduction as an Entry Point to Care

Overdose Prevention and Safer Contact

Harm reduction aims to decrease immediate injury, infection, overdose, and other adverse consequences while keeping pathways into treatment open. Depending on local law and service availability, this can include naloxone distribution and training, access to sterile injection supplies, infectious-disease testing, overdose education, wound care, and nonjudgmental clinical contact. The evidence base varies by intervention and outcome. A person should be offered proven treatments and the opportunity to reduce risk without having to promise immediate abstinence. Harm reduction services may establish trust that eventually supports clinical assessment and treatment engagement. Review of substance-use interventions in homeless populations, 2020; ASAM Engagement Guidance.

Public Health Services Integrated With Housing Outreach

Street outreach and shelter services can offer or coordinate vaccination, HIV and hepatitis screening, treatment referrals, wound evaluation, reproductive health services, and care for chronic diseases. Delivery needs to be responsive to privacy concerns, storage limits, weather exposure, and the ability to revisit patients. These activities are practical components of whole-person care even when a particular intervention has not been shown directly to reduce SUD symptoms. SAMHSA, Homelessness Programs and Resources.

Avoiding Coercion and Abrupt Disengagement

An encounter becomes more effective when the person can articulate goals and choose among clinically appropriate options. Coercive threats related to housing or support can damage trust and may discourage honest disclosure. Persistent use during treatment should trigger renewed safety assessment, consideration of treatment fit, and efforts to maintain contact. Policies that discharge everyone for recurrent substance use can convert a manageable clinical event into a dangerous interruption of care. ASAM Engagement Guidance.

Outreach, Case Management, and Integrated Systems

Outreach Is a Care Relationship, Not a Single Referral

Street outreach, mobile clinics, shelter-based programs, and community organizations may reach people who do not enter conventional clinics. Effective outreach requires repeated contacts, readiness to address immediate needs, pathways to timely prescriptions or clinical appointments, and clear follow-up. A 2026 systematic review and network meta-analysis of 35 studies examined models such as community reinforcement, assertive community treatment, intensive case management, and critical time intervention. Rankings suggested potential advantages for certain multicomponent models, but the community reinforcement point estimate cited for substance use had a confidence interval crossing zero. Network rankings should not be interpreted as definitive proof that a single model is universally superior. Ghafouri et al., 2026.

Case Management and Critical Transitions

Case management can coordinate housing applications, benefits, identification, transportation, medication continuity, and connections among medical and social providers. Transitions from hospital, jail, residential care, shelter, or temporary accommodation may carry disproportionate risks of lost treatment, interrupted medication, and overdose. Critical time intervention and other time-limited transition supports focus on maintaining contact during these handovers. A strong discharge plan identifies a concrete receiving service and a feasible means of accessing it, rather than listing referral telephone numbers alone. Ghafouri et al., 2026.

Peer Support and Shared Decision-Making

Peer workers can communicate practical knowledge, accompany people through systems, and model credible possibilities for recovery. Their effects depend on program structure, supervision, paid roles, local trust, and integration with clinical services. Peer support is complementary to professional diagnosis and pharmacologic treatment; it should not be substituted for emergency assessment or necessary medication. A person may prefer a peer worker with relevant lived experience, or may choose other forms of support.

Organizational Design Matters

Programs should evaluate how many eligible people initiate care, how quickly appointments occur, how often medications are interrupted, whether people feel safe and respected, and whether housing services are coordinated. A referral counted in an administrative database is not equivalent to completed treatment engagement. Outreach teams need realistic caseloads, staff training, care escalation procedures, and systems that can preserve privacy across agencies. Funding models and housing supply also limit what individual clinicians can accomplish.

Psychological Interventions and the Quality of Evidence

What Randomized and Comparative Studies Support

A 2025 Campbell systematic review synthesized 26 papers representing 23 intervention studies, all conducted in the United States. Across several psychosocial interventions, pooled effects favored the interventions on problematic substance use and mental health compared with usual services; the pooled housing-instability result remained uncertain. The mean standardized difference for substance-use outcomes was approximately −0.34, with a 95% confidence interval from −0.48 to −0.21. However, interventions and populations were heterogeneous, attrition was often high, and many studies had medium or high risk of bias. This supports cautious use of evidence-informed psychological services without claiming that any brief counseling approach can independently secure housing. O'Leary et al., 2025.

The same review examined contingency management, motivational interviewing, cognitive behavioral therapy, and brief motivational interventions. Effects varied by outcome, and several individual comparisons had confidence intervals compatible with little or no effect. Moreover, absence of evidence for a particular housing outcome cannot be converted into evidence of ineffectiveness. Evidence quality should be considered alongside feasibility, acceptability, and patient goals in each setting.

Lived Experience and Qualitative Evidence

Qualitative studies illuminate factors missed by numerical endpoints: perceived safety, dignity, autonomy, meaningful roles, family relationships, trauma, and whether service conditions feel achievable. A 2024 qualitative meta-synthesis described housing as foundational for many participants because security can make recovery activities possible. A 2025 qualitative evidence synthesis further examined how people experiencing homelessness experience psychosocial interventions and service relationships. These findings can guide humane service design, while causal treatment-effect claims require appropriate comparative research. Recovery experiences, 2024; O'Leary et al., 2025.

Housing First, Abstinence Programs, and False Certainty

Housing First and recovery housing have different eligibility conditions, mechanisms, and target populations. Housing First trials generally show stronger evidence for housing stability than for reductions in substance use. Recovery housing studies suggest potential substance-use and socioeconomic benefits in specific samples but remain relatively few. Findings do not justify forcing a single housing philosophy on all patients. Policy evaluation should distinguish who is served, who is excluded, how services are implemented, and which outcomes are measured. Baxter et al., 2019; Recovery housing review, 2025.

Recovery Support Beyond Clinical Remission

Recovery as Functioning and Social Stability

Recovery may involve reduced or discontinued substance use, remission of disorder symptoms, improved physical health, reliable housing, relationships, purposeful activity, and greater autonomy. For someone emerging from homelessness, obtaining stable accommodation or rebuilding access to primary care is a substantial outcome even if other goals require additional time. Equating recovery only with uninterrupted abstinence can miss clinically and socially important change. Conversely, improvement in housing status does not mean a disorder has automatically remitted. Both dimensions should be assessed. SAMHSA, Homelessness Programs and Resources.

Recovery Capital and Material Resources

Recovery capital is a way of describing practical, social, and personal resources that can support recovery. Housing is one important resource among income, education, skills, social relationships, safety, accessible health care, and community participation. People with scant material resources may exert tremendous effort merely to maintain a treatment routine. Expanding recovery resources means changing the surrounding opportunities as well as supporting individual behavior. The psychological construct should not be used to blame someone for lacking resources shaped by structural conditions.

Recurrence and Re-Engagement

A return to use can have different clinical meanings depending on quantity, consequences, safety risks, diagnostic criteria, and the person's goals. Recurrence after a period of reduced or absent use should trigger reassessment, attention to overdose risk and withdrawal, and adjustment of the treatment plan. Stable housing, medication access, meaningful follow-up, and nonpunitive clinical relationships help preserve opportunities for ongoing care. Relapse terminology should not become a reason to withdraw housing or essential medical support. ASAM Engagement Guidance.

Family, Relationships, Employment, and Community

Supportive relationships, income opportunities, legal assistance, education, and employment services can contribute to long-term functioning. These services must consider violence, coercion, discrimination, health limitations, and family conflict. Reconnection with relatives may be helpful for some people and dangerous for others. Clinical and social teams should identify meaningful goals collaboratively, revisit them over time, and document outcomes that matter to the person.

Populations Requiring Adapted Care

Adolescents and Young Adults

Young people experiencing homelessness may have developmental, educational, safeguarding, exploitation, and family-related vulnerabilities. Substance use screening should use age-appropriate methods, while treatment planning accounts for consent rules, safety, school participation, and developmental stage. Adult housing and addiction service assumptions do not automatically apply to minors. Supported housing and family interventions require careful individual evaluation, particularly where family environments are unsafe.

Pregnancy and Postpartum

Pregnant and postpartum patients need timely prenatal or postpartum care, attention to medications and polysubstance exposure, nutrition, safety, and stable accommodation. For opioid use disorder, ongoing evidence-based medication treatment is generally preferred to unsupported withdrawal because destabilization and recurrence can carry risks. The exact treatment and monitoring plan belongs to qualified clinicians and should respect informed consent. Housing insecurity may make prenatal attendance and continuity of care difficult. Clinical decisions should never be based on the assumption that pregnancy makes treatment inaccessible or undeserved.

Older Adults and People With Disabilities

Mobility limitations, cognitive impairment, multiple medications, falls, chronic pain, sensory disabilities, and medical frailty can alter both substance-related risk and accommodation suitability. Accessibility of shelters and housing, secure medication management, clinical follow-up, and social support may be decisive. The clinical team should distinguish symptoms due to substances from medical illness, medication adverse effects, and neurocognitive conditions.

Gender-Based Violence, Discrimination, and Justice Involvement

Some people experiencing homelessness also face intimate-partner violence, trafficking, racism, discrimination related to sexuality or gender, or exposure to incarceration. These circumstances can influence disclosure, eligibility, safety and trust. Services need trauma-sensitive referral pathways, confidential communication, and practical legal or safeguarding support. After incarceration or institutional discharge, medication continuity, naloxone access, and immediate housing linkage can be important components of transition planning.

Building a Practical Integrated Care Pathway

First Contact: Stabilize, Offer, Connect

A sensible first-contact pathway checks for life-threatening conditions, provides urgent care when needed, identifies immediate needs, and offers a clear next clinical step. It may include naloxone and overdose education, an evaluation for withdrawal, same-day connection to medication for opioid use disorder, wound care or infectious-disease testing, and assistance accessing food or shelter. The provider should check whether the proposed follow-up is genuinely reachable. A phone number alone is often insufficient when the person lacks a working telephone or reliable charging access.

Early Follow-Up: Reduce Friction

The next phase includes diagnostic assessment, shared decisions about evidence-based treatment, necessary laboratory or medical evaluations, and coordination with housing and benefits services. An identified care contact should track whether referrals were completed, with a privacy-conscious plan for outreach if appointments are missed. For severe comorbidities, coordinated mental and physical health services are preferable to repeated unconnected referrals. Staff should avoid changing medication or care intensity without appropriate clinical evaluation.

Continuing Care: Protect Stability

Long-term support involves ensuring access to medications, monitoring treatment response and side effects, addressing recurrence without abandonment, coordinating housing retention support, and attending to employment, income, relationships, and personal goals. The person’s priorities and willingness for particular services may change. Providers should measure both clinical outcomes and material conditions; one can improve while the other remains difficult. A clinically effective plan adapts to the realities of housing instability rather than assuming stable residence at every step.

Research Limitations and Future Questions

The strongest evidence pertains to some well-established treatments for specific SUDs and to the housing-stability outcomes of certain housing interventions. Homelessness-specific addiction-intervention trials are often smaller and more heterogeneous. Studies may exclude people with severe mental illness, complex polysubstance use, pregnancy, or the most unstable living situations, thereby limiting generalizability. High loss to follow-up can distort estimates when participants with the greatest instability are least likely to be assessed. Outcome measures differ across studies: abstinence, days of use, overdose, quality of life, housing nights, and utilization are not interchangeable. O'Leary et al., 2025; Ghafouri et al., 2026.

Promising approaches include low-barrier pharmacotherapy, coordinated housing and treatment, intensive case management, peer-supported outreach, and better transition services. The evidence is more convincing for some components than for particular multicomponent packages. Future high-quality evaluations need longer follow-up, inclusion of unsheltered populations, comparative implementation research, patient-defined outcomes, cost and equity analyses, and transparent reporting of harms or exclusions. Research should study how systems reduce repeated treatment interruption as well as how individual clinical symptoms change.

Frequently Asked Questions

Does homelessness cause addiction?

Homelessness can increase exposure to stress, disrupted care, unsafe environments, and other risks, while a substance use disorder can in some circumstances contribute to housing loss. Economic and social conditions also affect both. The relationship is bidirectional and varies among people. A causal statement about an individual requires specific history rather than an assumption based on housing status. ASAM, 2025.

Must a person stop using substances before receiving housing?

Housing eligibility depends on the program and jurisdiction. Housing First models offer access without requiring abstinence, while recovery housing programs may have abstinence-oriented expectations that are appropriate for some people who choose them. Research supports improved housing stability in Housing First models but does not consistently show that housing alone changes substance use. A person’s clinical care should remain available regardless of whether they have achieved abstinence. Baxter et al., 2019.

Can addiction treatment work without a permanent address?

Yes. Evidence-based care can begin through outreach, mobile, shelter-based, or low-barrier clinics; medication treatment for opioid use disorder is particularly important when indicated. Yet lack of secure housing can interrupt follow-up and medication access, so treatment should include practical continuity support. Observational and review evidence suggests that engagement in medication care is achievable even when housing is unstable. Opioid treatment scoping review, 2021.

Is Housing First an addiction treatment?

Housing First is a housing and support model with housing stability as a primary intended outcome. Addiction treatment refers to interventions aimed at SUD symptoms, harms, and functioning. Services can be combined, but the distinction is essential when evaluating evidence. Improved housing and reduced emergency care use do not automatically demonstrate remission of SUD. Baxter et al., 2019.

How do services help after recurrence of substance use?

Reassessment should address immediate safety, overdose risk, withdrawal, medication adherence, new stressors, and needed adjustments to treatment. Sustaining the care relationship and housing support can reduce further disruption. ASAM advises against routinely making abstinence a prerequisite for starting or remaining in substance use treatment. ASAM Engagement Guidance.

Which symptoms require emergency care?

Unresponsiveness, absent or severely slowed breathing, seizures, delirium or severe confusion, severe chest pain, collapse, severe hyperthermia, and immediate suicide risk require urgent medical evaluation. If an opioid overdose is suspected, call emergency services and use naloxone if available while following dispatcher instructions. Severe alcohol or sedative withdrawal also needs urgent professional assessment. CDC, Treating Opioid Use Disorder.

Related Articles

Cluster Substance Use Disorders and Addiction Recovery — the published clinical research chapter and the domain’s scientific navigation root.

Substance Use Disorder: Symptoms, Diagnosis, and Treatment — diagnostic criteria, assessment, clinical severity, and evidence-based care.

Substance Use Disorders and Suicide Risk: Evidence, Assessment, and Safety — risk assessment and coordinated safety planning where substance use disorders and suicidal behavior intersect.

Opioid Withdrawal: Symptoms, Timeline, and Treatment — substance-specific withdrawal assessment and medically supervised treatment.

Alcohol Use Disorder: Signs, Diagnosis, and Treatment — clinical diagnosis and longitudinal treatment for alcohol use disorder.

Stress and Addiction: Coping, Negative Reinforcement, and Relapse — psychological stress mechanisms that can influence substance-related behavior.

References

American Society of Addiction Medicine and American Academy of Addiction Psychiatry. (2024). The ASAM/AAAP clinical practice guideline on the management of stimulant use disorder. https://pmc.ncbi.nlm.nih.gov/articles/PMC11105801/

American Society of Addiction Medicine. (2024). Engagement and retention of nonabstinent patients in substance use treatment: Clinical considerations. https://www.asam.org/quality-care/clinical-recommendations/asam-clinical-considerations-for-engagement-and-retention-of-non-abstinent-patients-in-treatment

American Society of Addiction Medicine. (2025). Public policy statement on housing’s role in addressing substance use and facilitating recovery. https://downloads.asam.org/sitefinity-production-blobs/docs/default-source/public-policy-statements/2025-pps-on-housing%27s-role-in-addressing-substance-use.pdf

Baxter, A. J., Tweed, E. J., Katikireddi, S. V., and Thomson, H. (2019). Effects of Housing First approaches on health and well-being of adults who are homeless or at risk of homelessness: Systematic review and meta-analysis of randomized controlled trials. Journal of Epidemiology and Community Health, 73, 379–387. https://jech.bmj.com/content/73/5/379.abstract

Centers for Disease Control and Prevention. (2024). Treating opioid use disorder. https://www.cdc.gov/overdose-prevention/hcp/clinical-care/opioid-use-disorder-treating.html

Ghafouri, M., Meyerhoefer, T., Ali, D. N., Gregory, J., Taylor-Desir, M., Rummans, T. A., and Correa da Costa, S. (2026). Outreach models for substance use disorder in homeless populations: A systematic review and network meta-analysis. Psychiatric Services, 77. https://doi.org/10.1176/appi.ps.20250118

Office-based addiction treatment retention and mortality among people experiencing homelessness. (2021). JAMA Network Open. https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2776968

O'Leary, C., Coren, E., and Roberts, A. (2025). The experiences of adults experiencing homelessness when accessing and using psychosocial interventions: A systematic review and qualitative evidence synthesis. Campbell Systematic Reviews, 21, e70036. https://doi.org/10.1002/cl2.70036

O'Leary, C., Coren, E., Gellen, S., Roberts, A., and Armitage, H. (2025). The effectiveness of psychosocial interventions for reducing problematic substance use, mental ill health, and housing instability in people experiencing homelessness in high income countries: A systematic review and meta-analysis. Campbell Systematic Reviews, 21, e70019. https://doi.org/10.1002/cl2.70019

Opioid use disorder treatment for people experiencing homelessness: A scoping review. (2021). Drug and Alcohol Dependence. https://pmc.ncbi.nlm.nih.gov/articles/PMC9758007/

Prevalence of mental health disorders among individuals experiencing homelessness: A systematic review and meta-analysis. (2024). JAMA Psychiatry. https://doi.org/10.1001/jamapsychiatry.2024.0426

Recovery housing for substance use disorder: A systematic review. (2025). Frontiers in Public Health. https://doi.org/10.3389/fpubh.2025.1506412

Substance Abuse and Mental Health Services Administration. (2025). Homelessness programs and resources. https://www.samhsa.gov/communities/homelessness-programs-resources

Substance Abuse and Mental Health Services Administration. (2025). Treatment for individuals experiencing homelessness. https://www.samhsa.gov/communities/homelessness-programs-resources/tieh-program

Substance use interventions for homeless and vulnerably housed persons: A systematic review of systematic reviews. (2020). PLOS ONE. https://pmc.ncbi.nlm.nih.gov/articles/PMC6964917/

The recovery experiences of homeless service users with substance use disorder: A systematic review and qualitative meta-synthesis. (2024). International Journal of Drug Policy, 130, 104528. https://doi.org/10.1016/j.drugpo.2024.104528

World Health Organization and United Nations Office on Drugs and Crime. (2020). International standards for the treatment of drug use disorders. https://www.who.int/publications/i/item/international-standards-for-the-treatment-of-drug-use-disorders